Literature DB >> 22519424

The role of glia in retinal vascular disease.

Nathan J Coorey1, Weiyong Shen, Sook H Chung, Ling Zhu, Mark C Gillies.   

Abstract

Retinal vascular diseases collectively represent a leading cause of blindness. Unsurprisingly, pathological characterisation and treatment of retinal 'vascular' diseases have primarily focused on the aetiology and consequences of vascular dysfunction. Far less research has addressed the contribution of neuronal and glial dysfunction to the disease process of retinal vascular disorders. Ample evidence now suggests that retinal vasculopathy only uncommonly occurs in isolation, usually existing in concert with neuropathy and gliopathy. Retinal glia (Müller cells, astrocytes and microglia) have been reported to exhibit morphological and functional changes in both early and advanced phases of almost every retinal vascular disease. It is anticipated that identifying the causes of glial activation and dysfunction, and their contribution to loss of vision in retinal vascular disease, will lead to a better understanding of retinal vascular diseases, which might ultimately be translated into novel clinical therapies.
© 2012 The Authors. Clinical and Experimental Optometry © 2012 Optometrists Association Australia.

Entities:  

Mesh:

Year:  2012        PMID: 22519424     DOI: 10.1111/j.1444-0938.2012.00741.x

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  47 in total

1.  Ligand-functionalized nanoparticles target endothelial cells in retinal capillaries after systemic application.

Authors:  Klaus Pollinger; Robert Hennig; Andreas Ohlmann; Rudolf Fuchshofer; Rebecca Wenzel; Miriam Breunig; Joerg Tessmar; Ernst R Tamm; Achim Goepferich
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

2.  Angiogenic Factors and Cytokines in Diabetic Retinopathy.

Authors:  Steven F Abcouwer
Journal:  J Clin Cell Immunol       Date:  2013

3.  p75NTR and Its Ligand ProNGF Activate Paracrine Mechanisms Etiological to the Vascular, Inflammatory, and Neurodegenerative Pathologies of Diabetic Retinopathy.

Authors:  Pablo F Barcelona; Nicholas Sitaras; Alba Galan; Gema Esquiva; Sean Jmaeff; Yifan Jian; Marinko V Sarunic; Nicolas Cuenca; Przemyslaw Sapieha; H Uri Saragovi
Journal:  J Neurosci       Date:  2016-08-24       Impact factor: 6.167

4.  Targeting Neovascularization in Ischemic Retinopathy: Recent Advances.

Authors:  Mohamed Al-Shabrawey; Mohamed Elsherbiny; Julian Nussbaum; Amira Othman; Sylvia Megyerdi; Amany Tawfik
Journal:  Expert Rev Ophthalmol       Date:  2013-06

Review 5.  Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases.

Authors:  Melissa K Jones; Bin Lu; Sergey Girman; Shaomei Wang
Journal:  Prog Retin Eye Res       Date:  2017-01-19       Impact factor: 21.198

Review 6.  Muller glia in retinal innate immunity: a perspective on their roles in endophthalmitis.

Authors:  Ashok Kumar; Rajeev K Pandey; Lindsay J Miller; Pawan K Singh; Mamta Kanwar
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

7.  PACAP Is Protective in a Rat Model of Retinopathy of Prematurity.

Authors:  Timea Kvarik; Barbara Mammel; Dora Reglodi; Krisztina Kovacs; Dora Werling; Brigitta Bede; Alexandra Vaczy; Eszter Fabian; Gabor Toth; Peter Kiss; Andrea Tamas; Tibor Ertl; Judit Gyarmati; Tamas Atlasz
Journal:  J Mol Neurosci       Date:  2016-08-25       Impact factor: 3.444

Review 8.  Cerebral neovascularization in diabetes: implications for stroke recovery and beyond.

Authors:  Adviye Ergul; Mohammed Abdelsaid; Abdelrahman Y Fouda; Susan C Fagan
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-05       Impact factor: 6.200

9.  Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors Reduce Reactive Gliosis and Improve Angiostatin Levels in Retina of Diabetic Rats.

Authors:  Mykhailo M Guzyk; Artem A Tykhomyrov; Victor S Nedzvetsky; Irina V Prischepa; Tatiana V Grinenko; Lesya V Yanitska; Tamara M Kuchmerovska
Journal:  Neurochem Res       Date:  2016-06-02       Impact factor: 3.996

10.  Resveratrol Prevents Retinal Dysfunction by Regulating Glutamate Transporters, Glutamine Synthetase Expression and Activity in Diabetic Retina.

Authors:  Kaihong Zeng; Na Yang; Duozi Wang; Suping Li; Jian Ming; Jing Wang; Xuemei Yu; Yi Song; Xue Zhou; Yongtao Yang
Journal:  Neurochem Res       Date:  2015-12-16       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.